monitoring rheumatological disease
FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
Disease-modifying anti-rheumatic drugs (DMARDs) reduce tissue destruction by suppressing the auto-immune attack on the joints.
Serum acute phase proteins (ACP) are measured monthly to assess the effectiveness of DMARDs such as:
- methotrexate
- gold
- sulphasalazine
Last reviewed 01/2018
Links: